Meeting program

Thursday, October 12

*All times are in EET.

08:45 - 09:00 EET Opening remarks

  • A Vidovic (Serbia), D Antic (Serbia), D Coriu (Romania) & D Grujicic (Serbia)

09:00 - 10:30 EET Session 1: Acute myeloid leukemia - Diagnosis & therapy

Chairs: A Bogdanovic (Serbia) & H Bumbea (Romania)

  • State-of-the-Art lecture
    K Döhner (Germany)
  • Next Generation Sequencing in AML: to whom, why and when?
    M Radić Antolić (Croatia)
  • Flt3 positive AML patients: Experience of single center
    N Suvajdžić Vuković (Serbia)
  • How we can treat unfit AML patients?
    A Vidovic (Serbia)
  • Quizartinib for newly diagnosed acute myeloid leukemia patients 
    A Cili (Albania)
  • Panel discussion
    All speakers

10:30 - 10:45 EET Coffee break

10:45 - 12:15 EET Session 2: Acute myeloid leukemia - Therapies

Chairs: MC Ar (Türkiye) & S Trajkova (North Macedonia)

  • State-of-the-Art lecture
    B Huntly (United Kingdom)
  • Focusing on FLT3 inhibitors in acute myeloid leukemia
    C Stancioaica (Romania)
  • Relapsed/refractory AML patients: Therapeutic options
    S Anžej Doma (Slovenia)
  • Acute leukemia (M3) after liver transplantation
    M Aliona (Moldova)
  • Thrombosis in acute leukemias
    M Mitrović (Serbia)
  • Panel disucssion
    All speakers

12:15 - 12:45 EET Satellite Symposium: Novartis

12:15 - 13:15 EET Lunch

13:15 - 14:45 EET Session 3: Acute lymphoblastic leukemia - Diagnosis & therapy

Chairs: I Urosevic (Serbia) & E Grouzi (Greece)

  • State-of-the-Art lecture
    J Trka (Czech Republic)
  • ALL - Let's start with morphology and immunophenotype
    M Guenova (Bulgaria)
  • The place of MRD in the management of ALL
    D Darapınar (Türkiye)
  • Assessment of T-cell receptor gene rearrangement as a method for post induction minimal residual disease monitoring in adult patients with T-cell acute lymphoblastic leukemia
    N Ridova (North Macedonia)
  • Acute leukemia, associated with t(8;9)(p11;q33) and FGFR1 rearrangement: Diagnostic and therapeutic challenges
    P Voykov (Bulgaria)
  • Panel discussion
    All speakers

14:45 - 15:00 EET Coffee break

15:00 - 16:30 EET Session 4: Acute lymphoblastic leukemia - Therapies

Chairs: S Buruiana (Moldova) & A Ivanaj (Albania)

  • State-of-the-Art lecture
    M Mansour (United Kingdom)
  • The role of immune therapies in treatment of ALL patients
    E Ünal İnce (Türkiye)
  • The role of immunotherapy in R/R ALL
    B Todorova (Slovenia)
  • Chimeric Antigen Receptor T-Cell Therapy in Adult B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?
    P Tsirigotis (Greece)
  • Management of side effects of novel drugs in ALL
    V Blaslov (Croatia)
  • Panel discussion
    All speakers

16:30 - 17:00 Closing remarks

  • D Coriu (Romania), D Antic (Serbia) & A Vidovic (Serbia)

17:00 - 17:30 EET Satelite Symposium: Medica Linea